SV1994000083A - Derivados de indol, su preparacion y uso, ref. 1215ml/sv. - Google Patents

Derivados de indol, su preparacion y uso, ref. 1215ml/sv.

Info

Publication number
SV1994000083A
SV1994000083A SV1994000083A SV1994000083A SV1994000083A SV 1994000083 A SV1994000083 A SV 1994000083A SV 1994000083 A SV1994000083 A SV 1994000083A SV 1994000083 A SV1994000083 A SV 1994000083A SV 1994000083 A SV1994000083 A SV 1994000083A
Authority
SV
El Salvador
Prior art keywords
indol
ref
derivatives
preparation
formula
Prior art date
Application number
SV1994000083A
Other languages
English (en)
Inventor
Peter Charles North
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SV1994000083A publication Critical patent/SV1994000083A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

EL INVENTO SE RELACIOAN CON UN COMPUETO DE FORMULA I, Y SALES FARMACEUTICAMENTE ACEPTABLES Y SOLVATOS DE ELLA, UN COMPUESTO DE LA FORMULA I QUE ES UTIL EN EL TRATAIENTO DE CONDICIONES ASOCIADAS CON UNA FUNCION PERTURBADA DEL SISTEMA DE ELATONIA.
SV1994000083A 1993-12-22 1994-12-21 Derivados de indol, su preparacion y uso, ref. 1215ml/sv. SV1994000083A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939326192A GB9326192D0 (en) 1993-12-22 1993-12-22 Chemical compounds

Publications (1)

Publication Number Publication Date
SV1994000083A true SV1994000083A (es) 1995-07-24

Family

ID=10747030

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1994000083A SV1994000083A (es) 1993-12-22 1994-12-21 Derivados de indol, su preparacion y uso, ref. 1215ml/sv.

Country Status (15)

Country Link
US (1) US5633276A (es)
EP (1) EP0736028A1 (es)
JP (1) JPH09507057A (es)
AP (1) AP535A (es)
AU (1) AU684877B2 (es)
CA (1) CA2179402A1 (es)
CO (1) CO4340623A1 (es)
GB (1) GB9326192D0 (es)
IL (1) IL112097A (es)
IS (1) IS4244A (es)
MY (1) MY131641A (es)
SV (1) SV1994000083A (es)
TW (1) TW291479B (es)
WO (1) WO1995017405A1 (es)
ZA (1) ZA9410056B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
CN100443480C (zh) * 1996-03-08 2008-12-17 武田药品工业株式会社 三环化合物及其制备和用途
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
EP1199304A1 (en) * 1997-03-05 2002-04-24 Takeda Chemical Industries, Ltd. Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders
TW476758B (en) * 1996-12-10 2002-02-21 Bristol Myers Squibb Co Benzodioxole, benzofuran, dihydrobenzofuran and benzodioxane melatonergic agents
WO1998038991A1 (en) * 1997-03-05 1998-09-11 Bristol-Myers Squibb Company Polycyclic ethyl alkylamide melatonergic agents
FR2763335B1 (fr) * 1997-05-16 2000-11-24 Adir Nouveaux composes heterocycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU727654B2 (en) * 1997-06-13 2000-12-21 Yamanouchi Pharmaceutical Co., Ltd. Tricyclic pyrazole derivative
US6214869B1 (en) 1998-06-05 2001-04-10 Bristol-Myers Squibb Heterocyclic cis cyclopropane derivatives as melatonergic agents
DE60007745T2 (de) 1999-06-30 2005-03-10 Bristol-Myers Squibb Co. Heterocyclische aminopyrrolidon-derivate als melatonergene wirkstoffe
GB9918965D0 (en) * 1999-08-11 1999-10-13 Cerebrus Ltd Chemical compounds xxi
EP1213290B1 (en) 1999-08-20 2005-04-20 Takeda Pharmaceutical Company Limited Dihydrobenzofuran derivatives, process for the preparation thereof and agents
WO2001070745A1 (en) * 2000-03-17 2001-09-27 Alcon, Inc. Pyranoindoles for treating glaucoma
US7012090B1 (en) 2000-03-17 2006-03-14 Alcon, Inc. Pyranoindoles for treating glaucoma
ES2172415B2 (es) 2000-07-28 2003-11-16 Univ Madrid Complutense Tratamiento del glaucoma y la hipertension ocular por medio de un analogo de la melatonina.
WO2002055020A2 (en) * 2000-12-11 2002-07-18 Testocreme Llc Topical testosterone formulations and associated methods
US20030096379A1 (en) * 2001-03-28 2003-05-22 Kilgore James L. Method for producing tryptamine derivatives
TW200803837A (en) * 2006-03-20 2008-01-16 Takeda Pharmaceutical Prophylactic or therapeutic agent for irritable bowel syndrome
KR20090086641A (ko) * 2006-12-08 2009-08-13 다케다 야쿠힌 고교 가부시키가이샤 삼환 화합물 및 이의 의학적 용도
ES2331274B1 (es) * 2007-10-25 2010-10-21 Ferrer Internacional, S.A. Compuesto de indolina.
AR075262A1 (es) * 2008-07-30 2011-03-23 Ferrer Int Compuestos de 1,6-dihidro-2h-3-oxa-6-aza-as-indaceno, proceso para prepararlos, composicion farmaceutica que los comprende, sus usos como medicamentos, o en tratamientos o prevenciones de condiciones asociadas con un funcionamiento alterado de los sistemas regulados por la melatonina, sus usos para
BR102016024814A2 (pt) 2016-10-24 2018-05-08 Aché Laboratórios Farmacêuticos S.A. composto, processo de obtenção do composto, composição farmacêutica, uso do composto e método de tratamento de desordens psiquiátricas e/ou distúrbios do sono

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485539A1 (fr) * 1980-06-26 1981-12-31 Sori Soc Rech Ind Nouveau derive de pyranno-indole, son procede de preparation et son application en therapeutique
US4738972A (en) * 1985-05-21 1988-04-19 Pfizer Inc. Hypoglycemic thiazolidinediones
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect

Also Published As

Publication number Publication date
AP9400706A0 (en) 1995-01-31
IL112097A (en) 1998-06-15
IL112097A0 (en) 1995-03-15
CO4340623A1 (es) 1996-07-30
WO1995017405A1 (en) 1995-06-29
ZA9410056B (en) 1995-10-18
US5633276A (en) 1997-05-27
AU1274395A (en) 1995-07-10
GB9326192D0 (en) 1994-02-23
EP0736028A1 (en) 1996-10-09
JPH09507057A (ja) 1997-07-15
AP535A (en) 1996-09-16
CA2179402A1 (en) 1995-06-29
AU684877B2 (en) 1998-01-08
MY131641A (en) 2007-08-30
IS4244A (is) 1995-06-23
TW291479B (es) 1996-11-21

Similar Documents

Publication Publication Date Title
SV1994000083A (es) Derivados de indol, su preparacion y uso, ref. 1215ml/sv.
EA200100105A1 (ru) ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ ОКСАЗОЛОВ И ТИАЗОЛОВ В КАЧЕСТВЕ АКТИВАТОРОВ hPPAR ГАММА и hPPAR АЛЬФА
ES2195355T3 (es) Formulado farmaceutico que contiene voriconazol.
ES2114931T3 (es) Nuevos esteres esteroidales.
AR038434A2 (es) Compuesto 14,15-dihidro-16-oxoparahercuamida y compuestos 2-desoxo de parahercuamida y marcfortina
ES2195970T3 (es) L-ribavirina y usos de la misma.
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
ES2090713T3 (es) Sales organicas de n,n'-diacetil-cistina.
MX9203764A (es) Compuestos de heteroarilo monociclico y biciclico substituido por estirilo que inhiben la tirosina quimasa receptora del fce.
NL300103I2 (nl) Toepassing van tetrahydrocarbazoolderivaten als 5HT1-receptoragonisten.
DE69333062D1 (de) 4-mercaptoacetylamino-[2]benzazepinon(3)- derivate, und verwendung als enkephalinase-inhibitoren
NO943762L (no) Indolderivater som 5-HT 1 agonister
AR033325A1 (es) Composicion que comprende una carnitina y glutationa , util para incrementar la absorcion de la glutationa y sinergizar sus efectos, un complemento dietario, medicamento, la utilizacion de una composicion de combinacion para preparar un complemento dietario o un medicamento
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
ES2191985T3 (es) S-oxido de tetrahidrotiopirano feniloxazolidinonas.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
DE69834271D1 (de) Steroid-3-o-sulfamat-derivate als estronsulfatase-hemmer
NO954287D0 (no) Anvendelse av indolderivater som 5-HT1 agonister
ES2039200T3 (es) Derivados isotiazolonicos.
TR199802745T2 (xx) �kameli benzamid t�revleri ve bunlar�n ihtiya�lar� durdurucu veya engelleyici maddeler olarak kullan�lmas�.
ES2174113T3 (es) Nuevos derivados de ((3-alcoxi-fenoxi)-etil)-dialquilamina y su utilizacion como anestesicos locales.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
NO20011911L (no) Fluticasonv¶ske med forbedret vasokonstriktor aktivitet
UY24915A1 (es) Derivados de benzoxazindiona, aplicación de los mismos y medicamentos que los contienen